Trademarkia Logo

Canada

C$
ATHIRA
REGISTERED

on 17 Jan 2025

Last Applicant/ Owned by

Athira Pharma, Inc.

18706 North Creek Parkway, Suite 104Bothell Washington 98011

US

Serial Number

2263996 filed on 1st May 2023

Registration Number

TMA1284791 registered on 17th Jan 2025

Registration expiry Date

1st May 2033

ATHIRA

Trademark usage description

prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription p Read More

Classification Information


Class [005]
Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as alzheimer's disease, parkinson's disease, multiple sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis.


Classification kind code

12

Class [042]
Pharmaceutical research and development; pharmaceutical drug development services.


Classification kind code

12

Mark Details


Serial Number

2263996

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 3rd Oct 2024
Approval Notice Sent
Submitted for opposition 26
on 3rd Oct 2024
Approved
Submitted for opposition 22
on 24th Sept 2024
Search Recorded
Submitted for opposition 256
on 15th Apr 2024
Notification of Possible Opposition Sent
Submitted for opposition 135
on 24th Aug 2023
Amendment to Application
Submitted for opposition 257
on 15th Jun 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Jun 2023
Created
Submitted for opposition 31
on 14th Jun 2023
Formalized
Submitted for opposition 228
on 1st May 2023
International Registration
Submitted for opposition 30
on 1st May 2023
Filed